Regulatory Affairs
Optimi Health Ships Psilocybin to UK for Phase 2 Trial
The cross-border transfer required dual regulatory authorization from Health Canada and the UK Home Office, marking a p…
The cross-border transfer required dual regulatory authorization from Health Canada and the UK Home Office, marking a p…